SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description
   
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back




Title
: Emerging Challenges in Primary Care 2018 Uniondale, NY
Activity/Course #:
: 10.06.18PC
Cost:
: Free
Release/Start Date:
: Oct 06 2018
Expiration Date:
: Oct 06 2018
Topics:
: Primary Care Medicine
Target Audience:
: Primary Care Providers
Format:
: Live EC Primary Care
Estimated Time To Complete CME Activity:
: 6.5 hours
Credit(s):
: 6.5 AMA PRA Category I Credit(s)
4.0 AANP Contact hour(s)
2.5 ABIM MOC for physicians
2.5 ANCC with 2.0 hours pharmacotherapy for ARNPs
Hardware/Software Requirements:
This activity is jointly provided by National Association for Continuing Education, Postgraduate Institute for Medicine and DKBmed.
 
Saturday, October 6, 2018
Long Island Marriott Hotel & Conference Center
101 James Doolittle Boulevard
Uniondale, NY 11553
(516) 794-3800

Registration Fee
There is no registration fee for this activity.

Special Accommodations
NACE fully complies with the legal requirements of the Americans with Disabilities Act. Any activity registrant who feels s/he may need accommodations based on the impact of a disability should contact NACE to discuss your specific need.

Event Parking
Complimentary self-parking is available at the hotel.

Program Summary
Primary care providers face complex challenges everyday in their busy practices. With rapid changes in medicine, staying informed about new developments can be equally challenging. Our goal in this CME activity is to help you hone your skills in the diagnosis and management of patients with varied conditions you are likely encountering in your practice.

We have recruited a faculty of well-known thought leaders and experienced teachers who, as clinicians themselves, understand the challenges you face every day as a primary care provider. Our faculty will be at your disposal to provide evidence-based science, current treatment guidelines, discuss challenging cases, and provide answers for you that can ultimately lead to better health care for your patients. The presentations will include several interactive cases and discussion sessions to keep you actively learning.

Please join us and become an active participant in this one-day learning community of your peers.Learning Objectives

 Learning Objectives

  1. Recognize the pathogenesis of type 2 diabetes (T2DM) as a progressive, multi-defect disorder; Discuss the strengths and limitations of current guidelines for diabetes manager; Successfully use strategies for adherence to multiple medications to improve outcomes in diabetes; Examine data on current combination strategies to choose therapies that most effectively address a patient’s underlying pathophysiologic needs
  2. Discuss clinician and patient barriers to initiation and intensification of insulin therapy; Recognize the prevalence and clinical impact of hypoglycemia in special populations at risk; Discuss the pharmacology and clinical differences between existing and new long-acting and concentrated insulins; Discuss how to incorporate new basal and concentrated insulins into clinical practice while minimizing the risk of adverse events
  3. Review the risk factors and classification of pulmonary hypertension (PH); Discuss the appropriate diagnostic strategy for pulmonary arterial hypertension (PAH), including the roles of echocardiography, ventilation/perfusion (V/Q) scanning, and right heart catheterization (RHC); Review current and emerging treatments for patients with PAH; Describe how to monitor patients with PAH for disease progression
  4. Assess patients for treatment with ER/LA opioid analgesics; Evaluate and initiate therapy, modify dose, and discontinue use of ER/LA opioid analgesics; Manage ongoing therapy with ER/LA opioid analgesics; Perform effective counseling with patients and caregivers about the safe use of ER/LA opioid analgesics, including proper storage and disposal; Identify general and product-specific drug information concerning ER/LA opioid analgesics
  5. Describe the newer concepts in the pathophysiology of asthma and type 2 inflammation, and the implications of biologic therapies in the era of precision medicine; Determine the utility of simple biomarkers to identify patients who are candidates for targeted biologic therapies and appropriate referral; Discuss the impact of comorbid conditions on asthma control and the evidence-based approach to their treatment; Discuss the paradigms of multidisciplinary care in asthma, with an emphasis on patient and provider education, to improve adherence to inhalers and emerging biologic therapies in asthma
 
Agenda*

7:15-7:50

  Continental Breakfast and Registration
7:50-8:00   Welcome Remarks
Jack Kravitz, MD
8:00-9:00   The Progression of Type 2 Diabetes: A Rational Approach for Long Term Disease Management
Mark Stolar, MD
9:00-10:00   Safely Achieving Goals in Type 2 Diabetes (T2DM):The Role of Concentrated and Long-Acting Insulins
Mark Stolar, MD
10:00-10:20   Break
10:20-11:20   Evolving Strategies of Care in Pulmonary Arterial Hypertension: Integrating the Data into Practice
Alexander Duarte, MD
11:20-12:35   Safe Means of Administering the Right Therapy – Extended-Release and Long-Acting Opioids (Get SMART – Part I)
Michael R. Clark, MD, MPH, MBA and Yvonne D'Arcy, MS, ARNP-C, CNS, FAANP
12:35-1:30  

Lunch

1:30-2:45   Safe Means of Administering the Right Therapy – Extended-Release and Long-Acting Opioids (Get SMART – Part II)
Michael R. Clark, MD, MPH, MBA and Yvonne D'Arcy, MS, ARNP-C, CNS, FAANP
 2:45-3:45  

The Role of Type 2 Inflammation in Severe Persistent Asthma: Integrating Biologic Therapy to Optimize Outcomes
Sandra G. Adams, MD, MS

 3:45-4:00 

Program Summary and Closing Remarks
Jack Kravitz, MD

 
*Agenda subject to change.

Faculty

Sandra G. Adams, MD, MS
Professor, Division of Pulmonary Diseases and Critical Care Medicine
UT Health San Antonio
Staff Physician, The South Texas Veterans Health Care System
Founder, President
WipeDiseases Foundation
San Antonio, TX

Michael R. Clark, MD, MPH, MBA
Chair, Psychiatry & Behavioral Health
Inova Health System
Falls Church, VA

Yvonne D'Arcy, MS, ARNP-C, CNS, FAANP
Pain Management Nurse Practitioner
Ponte Vedra Beach, FL

Alexander Duarte, MD
Professor, Division of Pulmonary Critical Care & Sleep Medicine
Department of Internal Medicine
University of Texas Medical Branch
Galveston, TX

Jack Kravitz, MD

Family Practice
-Geriatrics
Coral Springs, FL

Mark Stolar, MD
Associate Professor of Clinical Medicine
Northwestern University Medical School
Chicago, IL

Planning Committee

Gregg Sherman, MD
Chief Medical Officer/Course Director
National Association for Continuing Education
Plantation, FL

Sheila Lucas, CWEP
Activity Director
National Association for Continuing Education
Plantation, FL

Michelle Frisch, MPH, CHCP
National Association for Continuing Education
Plantation, FL

Harvey C. Parker, Ph.D., CHCP
National Association for Continuing Education
Plantation, FL

Dean Beals
President & CEO
DKBmed
New York, NY

Rachel Deerr
Program Manager
DKBmed
New York, NY

Stan J. Pogroszewski, JD
COO/Director of Compliance
DKBmed
New York, NY
Sponsored and Certified By
National Association for Continuing Education and Postgraduate Institute for Medicine
Accreditation Designation Statement
Postgraduate Institute for Medicine
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and DKBmed. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 2.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 2.5 contact hours.
Designated for 2.0 contact hours of pharmacotherapy credit for Advance Practice Registered Nurses.

National Association for Continuing Education
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Association for Continuing Education designates this live activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 4 Contact hour(s) of continuing education which includes pharmacology hours.
Faculty Disclosure Policy
It is the policy of NACE to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by NACE are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. Faculty disclosure will be provided in the activity materials.

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.
Commercial Support
This activity is supported by an educational grant from Actelion Pharmaceuticals US, Inc., an educational grant from AstraZeneca Pharmaceuticals LP, an educational grant from Novo Nordisk Inc, and an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.

This activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies. Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully compliant with the ER/LA Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA).